Direxion Daily Biotech Top 5 Bull 2X ETF
TBXU
4 hedge funds and large institutions have $2.07M invested in Direxion Daily Biotech Top 5 Bull 2X ETF in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
30% more call options, than puts
Call options by funds: $16.8M | Put options by funds: $13M
1% more capital invested
Capital invested by funds: $2.05M → $2.07M (+$23.3K)
0.82% less ownership
Funds ownership: 65.27% → 64.45% (-0.82%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$21.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
-$46.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $803K | – | – | – |
|
2
Bank of America
Charlotte,
North Carolina
| $803K | – | – | – |
|
|
GS
3
GTS Securities
Miami,
Florida
| $442K | -$46.1K | -1,529 | -10% |
|
|
4
UBS Group
Zurich,
Switzerland
| $22.7K | +$21.3K | +706 | New |
|
TBXU Hedge Fund Activity: Q2 2026 in Review
4 of the 8,263 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) for Q2 2026, worth a combined $2.07M — up 1.1% from $2.05M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TBXU positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $21.3K. The largest seller was GTS Securities, cutting an estimated $46.1K.
- 4 institutional investors held Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) as of Q2 2026, up from 3 in Q1 2026.
- Funds reported $2.07M of Direxion Daily Biotech Top 5 Bull 2X ETF stock for Q2 2026, up 1.1% quarter-over-quarter.
- 1 fund opened new Direxion Daily Biotech Top 5 Bull 2X ETF positions in Q2 2026 and 0 closed out, a net change of +1 holder.
- The largest Direxion Daily Biotech Top 5 Bull 2X ETF buyer in Q2 2026 was UBS Group, an estimated $21.3K added.
- The largest Direxion Daily Biotech Top 5 Bull 2X ETF seller in Q2 2026 was GTS Securities, an estimated $46.1K sold.
Based on aggregated 13F filings for Q2 2026.